Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimal dose and safety of mivacurium chloride in laparoscopic cholecystectomy
ChiCTR2100043298Phase 4Recruiting
- Sponsor
- Zhongshan Hospital, Fudan University
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of mivacurium in cholecystitis, sponsored by Zhongshan Hospital, Fudan University. Primary endpoint: Degree of muscle relaxation. Started Dec 2020; status: recruiting.
02
Drugs
mivacurium
03
Conditions
cholecystitis
Beyond the preview
Go deeper on ChiCTR2100043298.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100043298.